ALK and rectal cancer: Fusions appeared to be more common in colo-rectal cancers with RET (CCDC6-RET), ALK (EMl4-ALK) and multiple fusions (RAF1, BRAF, and FGFR3) than in NSCLC patients, but larger studies are necessary to confirm this tendency [47].